Axon Enterprise
AXON
$310.44
Share price
0.72%
Change (1 day)
47.33%
Change (1 year)
Axon Enterprise (AXON) - P/B ratio
P/B ratio as of April 2024 : 14.4
According to Axon Enterprise
's latest financial reports the company has a price-to-book ratio of 14.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Axon Enterprise - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 12.0 | 28.99% |
| 2022-12-31 | 9.31 | -9.26% |
| 2021-12-31 | 10.3 | 28.18% |
| 2020-12-31 | 8.00 | -0.23% |
| 2019-12-31 | 8.02 | 45.71% |
| 2018-12-31 | 5.51 | -34.25% |
| 2017-12-31 | 8.37 | -0.3% |
| 2016-12-31 | 8.40 | 42.05% |
| 2015-12-31 | 5.91 | -45.61% |
| 2014-12-31 | 10.9 | 40.67% |
| 2013-12-31 | 7.73 | 42.98% |
| 2012-12-31 | 5.40 | 56.61% |
| 2011-12-31 | 3.45 | 37.86% |
| 2010-12-31 | 2.50 | 8.3% |
| 2009-12-31 | 2.31 | -20.17% |
| 2008-12-31 | 2.90 | -61.45% |
| 2007-12-31 | 7.51 | 59.04% |
| 2006-12-31 | 4.72 | 13.64% |
| 2005-12-31 | 4.16 | -78.49% |
| 2004-12-31 | 19.3 | 52.28% |
| 2003-12-31 | 12.7 | 569.96% |
| 2002-12-31 | 1.89 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 XBiotech XBIT | 1.10 | -92.41% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | 1.30 | -91.02% | 🇺🇸 USA |
 Exelixis EXEL | 3.09 | -78.61% | 🇺🇸 USA |